PGK1 and central nervous system cancer: In recent studies, NG52 was shown to target the kinase activity of PGK1 and reverse the Warburg effect by inhibiting the phosphorylation of PDHK1 at residue Thr338 site and enhancing the activity of pyruvate dehydrogenase (PDH) in glioma cells (44).